Which hedge funds own TCRX? TSCAN THERAPEUTICS INC, Q2 2026 13F holders
Follow
12 tracked hedge funds disclosed a position in TCRX (TSCAN THERAPEUTICS INC) in their Q2 2026 13F filings, worth $18.7m in total. The largest holder by portfolio weight is Lynx1 Capital Management LP at 0.9% of its book. 2 opened a new position this quarter: Boothbay Fund Management, LLC, Landscape Capital Management, L.L.C.. 1 exited: NINE MASTS CAPITAL Ltd.
12
Holders
Tracked managers whose filing for the quarter reports a long equity position in the security.
2
New this quarter
Holders whose previous filing (at most two quarters earlier) did not report the security.
1
Exited this quarter
Tracked managers whose previous filing reported the security and whose filing for the quarter does not.
$782k
Inflow, new holders
Combined value of the positions the new holders reported for the quarter.
$42.2k
Outflow, exits
Combined value the exiting managers reported for the security in their previous filing.
$18.7m
Combined value
Sum of the holders' reported positions in the security.
1.0%
Share of managers holding
Holders as a share of tracked managers filing for that quarter. Comparable across the 2024 coverage expansion, where the raw holder count is not.